Fri.Jun 28, 2024

article thumbnail

Protein maps in cerebrospinal fluid offer insight into Alzheimer’s biology

STAT

Fighting Alzheimer’s disease is a race against time. By the time most patients are diagnosed and treated, their cognitive symptoms have already advanced significantly. New research, though, pinpoints protein changes in cerebrospinal fluid highly associated with the development of Alzheimer’s disease. A better biological understanding of the brain disorder could foster new treatments and earlier intervention — as early as 20 years before onset of symptoms according to models

345
345
article thumbnail

Up-and-comers look for an edge in the bustling ADC field

PharmaVoice

The next wave of targeted ADC therapies is on the horizon, and these three potential rising stars could help carry the field forward.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How U.S. responses to public health emergencies could be hamstrung by the Supreme Court

STAT

WASHINGTON — The U.S. response to the Covid-19 pandemic got politically messy. A Friday Supreme Court ruling could frustrate government responses to public health emergencies even further. The Supreme Court struck down a long-standing legal doctrine that directed judges to defer to reasonable federal agency interpretations of ambiguous or technically challenging aspects of the law.

329
329
article thumbnail

Why progress on ovarian cancer treatments is slow

pharmaphorum

Progress on ovarian cancer treatments has been slow, despite promising drugs like Keytruda and Lynparza. Learn about the obstacles and challenges in developing effective treatments for this deadly disease.

121
121
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Blind employee takes VA to court saying new EHR from Oracle is inaccessible

STAT

A blind employee of the Department of Veterans Affairs is suing the federal agency on grounds that their new electronic health records system makes it impossible for her to do her job. A clinical social worker, Laurette Santos has worked for the VA for a decade, but when the agency switched to Oracle Health’s Cerner EHR in 2022, her productivity plummeted.

article thumbnail

Innovative small molecule shows promise in obesity

European Pharmaceutical Review

An innovative oral small molecule GLP-1 receptor agonist enabled patients to obtain an average weight loss of 4.9 percent to 6.8 percent (least squares means) from baseline by day 28, in a Phase I trial. This was based on individuals who received the treatment in the target dose range. HUADONG MEDICINE, via its subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO.

More Trending

article thumbnail

Discover The Impact Of Vitamin B1 On Blood Pressure | A Comprehensive Overview

Welltopia Pharmacy

Vitamin B1, or thiamine, is an essential nutrient that plays a critical role in the body’s metabolic processes. This water-soluble vitamin is crucial for converting carbohydrates into energy and maintaining proper function of the heart, muscles, and nervous system.

104
104
article thumbnail

Upending Purdue Pharma’s settlement does little to help today’s opioid crisis, advocates say

STAT

The drug policy world has been left torn by the Supreme Court’s ruling on Thursday that Purdue Pharma’s bankruptcy deal could not move forward if it included legal protections for the company’s billionaire owners. In one camp are those who were eager to see the agreed-upon $6 billion settlement put to work preventing and treating opioid addiction.

290
290
article thumbnail

Pride in Pharmacy: confidence in providing equitable healthcare

The Pharmacist

Reuben Dunbar shares how the Pride in Pharmacy training and support programme aims to help pharmacy teams feel confident in the ways they can provide more equitable healthcare to LGBTQ+ people. Why is Pride in Pharmacy important for both pharmacy teams and patients? The aim of Pride in Pharmacy is for every LGBTQ+ person to […] The post Pride in Pharmacy: confidence in providing equitable healthcare appeared first on The Pharmacist.

103
103
article thumbnail

STAT+: Don’t write off MDMA yet: How the FDA got on board with psychedelics

STAT

Days after an advisory committee resoundingly voted for the Food and Drug Administration to reject MDMA as medical treatment, the founder of the company that applied for approval was ebullient. Rick Doblin, who has spent decades driving forward MDMA research, told a psychedelics conference in the Netherlands that his dream was not simply possible, but likely.

276
276
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Supreme Court overturns Chevron doctrine, limiting reach of federal agencies

BioPharma Dive

Federal courts will no longer have to defer to agency regulations for interpretation of ambiguous statutes, a ruling that could have significant impact on the FDA and CMS.

102
102
article thumbnail

Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Morning! Today, we discuss how a House committee has overwhelmingly voted in support of four health-related bills. Also, there’s still reason to believe that MDMA-assisted therapy could win FDA approval, and more.

article thumbnail

NHSE updates on PGD change for pharmacy technicians

The Pharmacist

NHS England (NHSE) is has issued an update on potential changes to its service specifications in light of recent legislative amendments that allow pharmacy technicians to supply medicines under patient group directions (PGDs). In a primary care bulletin sent last night, NHSE said it was ‘developing processes’ to ‘consider updating’ NHS service specifications ‘in light […] The post NHSE updates on PGD change for pharmacy technicians appeared first on The Pharmacist.

article thumbnail

Opinion: Medicare’s Part D policy is blocking progress needed to achieve Black health equity

STAT

A new and effective class of anti-obesity medicines, along with lifestyle interventions and sometimes bariatric surgery, can help stem the rising tide of obesity in the United States. But outdated rules set by the Centers for Medicare and Medicaid Services make access to these new medicines nearly impossible for the 50 million Americans covered by Medicare and its prescription drug coverage program.

270
270
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

House committee backs some Medicare cover for obesity drugs

pharmaphorum

The House Ways and Means Committee in the US voted in favour of a new bill which would end a two-decade-long restriction on the coverage of drugs to treat obesity under Medicare.The Treat and Reduce Obesity Act of 2023 (TROA) was originally intended to overturn the restriction completely, but has been hugely scaled back in its scope.

106
106
article thumbnail

Opinion: To secure the U.S.’s biotech supply chain, pay attention to domestic companies

STAT

Scientific breakthroughs will enable a future of personalized drug discovery, where precision medicine makes it possible to receive the right dose of the right medicine at the right time. America’s ability to lead this global frontier of medicine is contingent upon our willingness to recognize China as a competitor and respond accordingly. But often overlooked in this essential conversation is the importance of investing more in U.S. biotech firms and innovation ecosystems — includ

261
261
article thumbnail

10th edition of PharmaLytica held in Hyderabad

Express Pharma

The 10th edition of PharmaLytica, organised by Informa Markets in India concluded at HITEX, Hyderabad. With a focus on redefining the pharmaceutical industry in the post-COVID era, PharmaLytica 2024 offered a platform for stakeholders to engage in discussions covering the full spectrum of pharma machinery and packaging, lab analytical and cleanroom solutions, and pharmaceutical ingredients.

Packaging 100
article thumbnail

STAT+: Cassava Sciences collaborator charged with defrauding NIH in grants supporting its Alzheimer’s drug

STAT

A Cassava Sciences collaborator and paid consultant has been indicted by a federal grand jury on charges of defrauding the National Institutes of Health in grant applications supporting the company’s controversial Alzheimer’s drug, the U.S. Department of Justice announced on Friday. Hoau-Yan Wang, 67, a neuroscientist at the City University of New York, published key papers supporting the effectiveness of simufilam, an experimental Alzheimer’s therapy Cassava is now testing

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Amazon bundles its telehealth services under one brand

pharmaphorum

Amazon’s strategy in telehealth has coalesced around a pay-per-visit and subscription-based model under a new brand – Amazon One Medical.

115
115
article thumbnail

STAT+: Optum walks away from its agreement to buy Steward’s doctors network

STAT

Health care provider Optum has backed away from its plan to purchase Steward Health Care’s national physicians group, dealing a major setback to Steward’s efforts to bolster its finances after filing for bankruptcy. Optum, an arm of health insurance giant UnitedHealth, struck a preliminary deal in March to acquire Stewardship Health for an undisclosed sum.

Hospitals 254
article thumbnail

Amylyx ventures into metabolic diseases market with $35.1m deal

Pharmaceutical Technology

On 17 June, Amylyx acquired the rights to Eiger Biopharmaceutical’s experimental GLP-1 receptor antagonist, avexitide, for $35.1m.

105
105
article thumbnail

STAT+: Pharmalittle: We’re reading about the Purdue bankruptcy ruling, a Merck rejection, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is fairly modest. We hope to catch up on our reading, spend time with our Pharmalot ancestor, and promenade with the official mascots. We also hope to hold another listening party, where the rotation will likely feature this , this , this , this , and this.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

IPA hosts Global Pharmaceutical Quality Summit 2024

Express Pharma

Indian Pharmaceutical Alliance (IPA) concluded the 9th edition of the Global Pharmaceutical Quality Summit 2024. The theme for the summit was, ‘Advances in Manufacturing and Quality – Patient Centricity’. The two-day summit brought together industry leaders, global regulators, quality experts, and stakeholders to foster knowledge exchange and deliberate on areas of importance in shaping the pharmaceutical landscape in India.

article thumbnail

STAT+: Vape makers see Supreme Court ruling as a weapon in fighting FDA

STAT

WASHINGTON — Vape manufacturers are taking a victory lap over a Supreme Court decision that could dramatically weaken the Food and Drug Administration’s power to regulate tobacco and nicotine products as regulators see fit. The court on Friday overturned a judicial rule, known as the Chevron doctrine, which instructed courts to defer to regulators on certain legal issues.

241
241
article thumbnail

Osteoporosis market to reach $17.9 bn across 7MM in 2033: GlobalData

Express Pharma

The osteoporosis market, the prevailing metabolic bone disorder globally, which is characterised by reduced bone mineral density and increased fracture risk, is set to experience a compound annual growth rate (CAGR) of 5.4 per cent across the seven major markets (7MM*) from $10.5 billion in 2023 to $17.9 billion in 2033, forecasts GlobalData. GlobalData’s latest report, “Seven-Market Drug Forecast and Market Analysis”, reveals the rising popularity of expensive anabolic therapies and increasing

article thumbnail

STAT+: Drug wholesaler owners indicted for alleged role in diverting Gilead and J&J HIV medicines

STAT

The owners of a drug wholesaler have been indicted for their alleged role in a conspiracy to distribute misbranded and diverted HIV pills, the latest effort by federal authorities to target a widespread scheme to pump the medicines into the U.S. pharmaceutical supply chain. Patrick Boyd and Charles Boyd, who own Safe Chain Solutions, along with a broker, Adam Brosius, were indicted for allegedly buying more than $90 million of “heavily discounted” prescription drugs from a handful

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Revised Schedule M audits to test will, skill of regulators and regulated

Express Pharma

From July 1, India’s medicines watchdog, the Central Drugs Standard Control Organisation (CDSCO), will start risk-based unannounced audits of pharma companies with a turnover over Rs 250 crore as per the revised Schedule M. Smaller companies have six months more to gear up for revised Schedule M audits. But it is interesting to note that even as all global regulators, especially the US FDA, raise the bar on quality expectations, and major pharma companies in India express a willingness to

84
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

181
181
article thumbnail

UK study reveals persistent challenges in heart health and cardiovascular diseases

Pharma Times

The study found an increase in incidence among young people and people from deprived areas

104
104
article thumbnail

ASCO 2024 – Thanos Zomas

pharmaphorum

Stay updated on ASCO 2024 with Dr Thanos Zomas, a leading expert in oncology and a key figure at Takeda. Learn about the latest advancements in cancer treatment and research.

79
article thumbnail

Orchid Pharma, Cipla to launch antibiotic Cefepime-Enmetazobactam in India

Express Pharma

Orchid Pharma, announced the launch of its new drug – Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications. Orchid Pharma has partnered with Cipla to ensure widespread and rapid distribution of this antibiotic combination across India.